Table 2.
Characteristics of included studies.
| Trial | Design | Patients | Age (mean) | %male | Tx Duration (mos) | Jadad Score | Jadad Problems |
|---|---|---|---|---|---|---|---|
| Agnelli et al. [6] | RCT | 90 | — | — | 12 | 6 | Not double blind |
| 91 | — | — | 3 | ||||
| Agnelli et al. [7] | RCT | 134 | 67 | 55 | 12 | 6 | Not double blind |
| 133 | 68 | 61 | 3 | ||||
| Farraj [20] | RCT | 32 | 41 | 62 | 24 | 4 | Not double blind Withdrawals/dropouts No statistics methods |
| 32 | 42 | 56 | 6 | ||||
| Legnani et al. [24] | Cohort | 628 | 67 | 53 | 7 | 4 | Not randomized |
| Kyrle et al. [22] | Cohort | 453 | 45 | 0 | 9 | 4 | Not randomized |
| 373 | 51 | 100 | 8 | ||||
| Palareti et al. [19] | RCT | 385 | 59 | 55 | 13.0 | 6 | Not double blind |
| 120 | 68 | 42 | 10.8 | ||||
| Palareti et al. [25] | Cohort | 282 | 70 | 55 | 7.5 | 4 | Not randomized |
| Schulman et al. [21] | RCT | 289 | 63 | 63 | 6 | 6 | Not double blind |
| Poli et al. [23] | Cohort | 183 | 60 | 57 | 14.9 | 3 | Not randomized |